NHNK.Y Stock Overview
Engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Nihon Kohden Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥14.96 |
| 52 Week High | JP¥20.00 |
| 52 Week Low | JP¥10.06 |
| Beta | 0.00039 |
| 11 Month Change | -1.58% |
| 3 Month Change | 33.45% |
| 1 Year Change | 20.79% |
| 33 Year Change | -3.11% |
| 5 Year Change | 10.57% |
| Change since IPO | 44.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| NHNK.Y | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 3.2% | 0.2% | -1.6% |
| 1Y | 20.8% | 25.8% | 30.8% |
Return vs Industry: NHNK.Y underperformed the US Medical Equipment industry which returned 25.8% over the past year.
Return vs Market: NHNK.Y underperformed the US Market which returned 30.8% over the past year.
Price Volatility
| NHNK.Y volatility | |
|---|---|
| NHNK.Y Average Weekly Movement | 14.6% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: NHNK.Y's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: NHNK.Y's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1951 | 5,891 | Hirokazu Ogino | www.nihonkohden.com |
Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers. The company also provides medical support system, which includes diagnostic and clinical information system; and in-vitro diagnostic equipment comprising hematology and clinical chemistry analyzers.
Nihon Kohden Corporation Fundamentals Summary
| NHNK.Y fundamental statistics | |
|---|---|
| Market cap | US$2.43b |
| Earnings (TTM) | US$91.55m |
| Revenue (TTM) | US$1.43b |
26.6x
P/E Ratio1.7x
P/S RatioIs NHNK.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NHNK.Y income statement (TTM) | |
|---|---|
| Revenue | JP¥219.49b |
| Cost of Revenue | JP¥110.63b |
| Gross Profit | JP¥108.85b |
| Other Expenses | JP¥94.85b |
| Earnings | JP¥14.01b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 07, 2024
| Earnings per share (EPS) | 84.05 |
| Gross Margin | 49.59% |
| Net Profit Margin | 6.38% |
| Debt/Equity Ratio | 0.3% |
How did NHNK.Y perform over the long term?
See historical performance and comparison